An experimental drug has been found to reduce the risk of death from blood vessel rupture in mice. The drug also appears to lower "bad" cholesterol, with some reports suggesting it can cut levels by as much as 60-62% and reduce heart attack risk. However, the specific benefits and details of the drug's effects in humans, including its potential to replace existing treatments like statins, are still unclear.